Abiraterone Acetate Reduced Impurity

Abiraterone Acetate Reduced Impurity

VS CAT No VS-A006045
CAS No 2141996-19-0
Mol.F. C26H35NO2
Mol.Wt. 393.6
Inv. Status Custom Synthesis

Chemical Name: (3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Shipping Temperature: Ambient

Country of Origin: India

Smiles: C[C@@]1(C(C2=CN=CC=C2)=CC3)[C@]3([H])[C@@](CCC4[C@@]5(CC[C@H](OC(C)=O)C4)C)([H])[C@]5([H])CC1

Abiraterone Acetate Reduced Impurity is chemically (3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate. Abiraterone Acetate Reduced Impurity is supplied with detailed characterization data compliant with regulatory guideline. Abiraterone Acetate Reduced Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abiraterone Acetate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.